by VH102021 | Mar 9, 2022 | News&events
VisMederi Srl took part into research on antibody and cellular response induced by mRna vaccine against Covid-19. This trial involved a group of 352 healthcare workers, 180 days after the second shot of Pfizer-Biontech mRna vaccine. VisMederi founder and CSO Emanuele...
by VH102021 | Mar 9, 2022 | News&events
VisMederi Textyle, the VisMederi group company dealing with Quality Control on textile materials, becomes the reference centre for the international non-profit association Peta “People for the Ethical Treatment of Animals”. “Our task – CEO Giovanni Micheli says – is...
